Mass Spectrometry Data Confidence Points Mass spectrometry data add confidence when the expected molecular weight, mass-to-charge data, and method documentation align
The MHRA can consider the ingredient, formulation, route, claims, imagery, testimonials, instructions and overall commercial presentation
3 :d1d10
Developing anti-inflammatory therapeutics for patients with osteoarthritis
Patients are encouraged to report any suspected side effects to the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk), which helps monitor the safety of medicines after they've been licensed
Future research directions include expanded safety studies, efficacy trials, and long-term outcome assessments